Company intelligence / Profile preview

Avet Pharmaceuticals Inc.

East Brunswick, New Jersey, United Statesavetpharma.com ↗

Ownership: Private
Employees: ~180
Development stage: Commercial

Overview

The company has a robust commercial portfolio of more than two dozen FDA-approved generic prescription products across multiple therapeutic areas. It has experienced rapid growth but has also faced legal scrutiny related to price-fixing allegations in the US generics market. As of late October/November 2024 it operates under the name Avet Pharmaceuticals following rebranding from Heritage.

Therapeutic areas: OncologyMetabolic DisordersCardiovascularNeurologyInfectious Diseases
Modalities: Small molecules (oral solids, injectables, powders for suspension)
Industry: Biotech

Drug pipeline

2 assets

doxycycline

Commercial

Indications: Bacterial infections

1 more asset in the full pipeline.

Request access →

Partnerships

Dexcel Ltd. – exclusive development/supply/distribution agreement for extended-release ANDA drug product

Beyond the preview

Go deeper on Avet Pharmaceuticals Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avet Pharmaceuticals Inc..

Explore the full profile